Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 92 M80 M80.4 M104.97 M89.84 M 355.22 M Research & development ————— — Operating income 263.96 M306.73 M391.73 M542.31 M369.71 M 1.61 B Non-Operating Income, Total ————— — Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 29.43 M48.92 M107.43 M188.76 M87.93 M 433.05 M Equity in earnings ————— — Taxes -7.33 M17.17 M24.95 M45.8 M19.62 M 107.54 M Non-controlling/minority interest -28.15 M-10.43 M22.21 M29 M3.07 M 43.85 M After tax other income/expense ————— — Net income before discontinued operations 64.92 M42.18 M60.27 M113.97 M65.24 M 281.66 M Discontinued operations ————— — Net income 64.92 M42.18 M60.27 M113.97 M65.24 M 281.66 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 64.92 M42.18 M60.27 M113.97 M65.24 M 281.66 M Basic earnings per share (Basic EPS) 0.990.630.91.690.96 4.19 Diluted earnings per share (Diluted EPS) 0.910.590.841.60.92 3.96 Average basic shares outstanding 65.51 M66.81 M66.86 M67.32 M67.84 M — Diluted shares outstanding 71.15 M70.9 M71.23 M71.25 M71.23 M — EBITDA 274.99 M312.96 M398.54 M556.74 M376.5 M 1.64 B EBIT 263.96 M306.73 M391.73 M542.31 M369.71 M 1.61 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 6.29 M6.23 M6.81 M14.43 M6.79 M 34.26 M